{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T09:18:08Z","timestamp":1788427088766,"version":"build-2803163510"},"reference-count":30,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2016,7,1]],"date-time":"2016-07-01T00:00:00Z","timestamp":1467331200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","lipidjournal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Lipidology"],"published-print":{"date-parts":[[2016,7]]},"DOI":"10.1016\/j.jacl.2016.04.006","type":"journal-article","created":{"date-parts":[[2016,4,30]],"date-time":"2016-04-30T20:25:24Z","timestamp":1462047924000},"page":"953-961","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":52,"title":["Clinical and molecular characteristics of homozygous familial hypercholesterolemia patients: Insights from SAFEHEART registry"],"prefix":"10.1016","volume":"10","author":[{"given":"Rodrigo","family":"Alonso","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose Luis","family":"D\u00edaz-D\u00edaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco","family":"Arrieta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco","family":"Fuentes-Jim\u00e9nez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raimundo","family":"de Andr\u00e9s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro","family":"Saenz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gema","family":"Ariceta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 I.","family":"Vidal-Pardo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatima","family":"Almagro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosa","family":"Argueso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pablo","family":"Prieto-Matos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 P.","family":"Miramontes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xavier","family":"Pint\u00f3","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johana","family":"Rodriguez-Urrego","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leopoldo","family":"Perez de Isla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro","family":"Mata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacl.2016.04.006_bib1","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1016\/S0140-6736(11)61476-1","article-title":"Homozygous familial hypercholesterolaemia","volume":"379","author":"Macchiaiolo","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.jacl.2016.04.006_bib2","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1172\/JCI200318925","article-title":"Monogenic hypercholesterolemia: new insights in pathogenesis and treatment","volume":"111","author":"Rader","year":"2003","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jacl.2016.04.006_bib3","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.jacl.2014.09.005","article-title":"The doctor's dilemma: challenges in the diagnosis and care of homozygous familial hypercholesterolemia","volume":"8","author":"Baum","year":"2014","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.jacl.2016.04.006_bib4","doi-asserted-by":"crossref","first-page":"2146","DOI":"10.1093\/eurheartj\/ehu274","article-title":"Homozygous familial Hypercholesterolemia: new insights and guidance for clinicians to improve detection and clinical management. A position paper from the Consensus Panel on familial Hypercholesterolemia of the European Atherosclerosis Society","volume":"35","author":"Cuchel","year":"2014","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacl.2016.04.006_bib5","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1093\/eurheartj\/ehu058","article-title":"Homozygous autosomal dominant hypercholesterolemia in the Netherlands: prevalence, genotype-phenotype relationship, and clinical outcome","volume":"36","author":"Sjouke","year":"2015","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacl.2016.04.006_bib6","first-page":"49","article-title":"Familial hypercholesterolaemia","volume":"25","author":"Marais","year":"2004","journal-title":"Clin Biochem Rev"},{"key":"10.1016\/j.jacl.2016.04.006_bib7","series-title":"The Metabolic Basis of Inherited Disease","first-page":"2863","article-title":"Familial Hypercholesterolemia","author":"Goldstein","year":"2001"},{"key":"10.1016\/j.jacl.2016.04.006_bib8","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.atherosclerosis.2012.02.019","article-title":"Homozygous familial hypercholesterolemia: current perspectives on diagnosis and treatment","volume":"223","author":"Raal","year":"2012","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jacl.2016.04.006_bib9","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.ijcard.2013.11.025","article-title":"Integrated guidance on the care of familial hypercholesterolaemia from the International FH Foundation","volume":"171","author":"Watts","year":"2014","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jacl.2016.04.006_bib10","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/S0140-6736(12)61731-0","article-title":"Phase 3 HoFH Lomitapide Study investigators. Efficacy and safety of a microsomal triglyceride transfer protein inhibitor in patients with homozygous familial hypercholesterolemia: A single-arm, open-label, phase 3 study","volume":"381","author":"Cuchel","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.jacl.2016.04.006_bib11","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/S0140-6736(10)60284-X","article-title":"Mipomersen, an apolipoprotein B synthesis inhibitor, for lowering of LDL cholesterol concentrations in patients with homozygous familial hypercholesterolemia: a randomized, doubled-blind, placebo-controlled trial","volume":"375","author":"Raal","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.jacl.2016.04.006_bib12","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/S0140-6736(14)61374-X","article-title":"Inhibition\u00a0of PCSK9 with evolocumab in homozygous familial hypercholesterolemia (TESLA Part B): a randomised, double-blind, placebo-controlled trial","volume":"385","author":"Raal","year":"2015","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.jacl.2016.04.006_bib13","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1186\/1476-511X-10-94","article-title":"Clinical characteristics and evaluation of LDL- cholesterol treatment of the Spanish Familial Hypercholesterolemia Longitudinal Cohort Study (SAFEHEART)","volume":"10","author":"Mata","year":"2011","journal-title":"Lipids Health Dis"},{"key":"10.1016\/j.jacl.2016.04.006_bib14","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/j.clinbiochem.2009.01.017","article-title":"Genetic Diagnosis of Familial Hypercholesterolemia using a DNA-array based platform","volume":"42","author":"Alonso","year":"2009","journal-title":"Clin Biochem"},{"key":"10.1016\/j.jacl.2016.04.006_bib15","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.1161\/01.ATV.0000094410.66558.9A","article-title":"Genetics, clinical phenotype, and molecular cell biology of autosomal recessive hypercholesterolemia","volume":"23","author":"Soutar","year":"2003","journal-title":"Arterioscler Thromb Vascbiol"},{"key":"10.1016\/j.jacl.2016.04.006_bib16","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.jacl.2015.05.001","article-title":"Treating homozygous familial hypercholesterolemia in a real-world setting: Experiences with lomitapide","volume":"9","author":"Roeters van Lennep","year":"2015","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.jacl.2016.04.006_bib17","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.atherosclerosis.2016.03.009","article-title":"Phenotype diversity among patients with homozygous familial hypercholesterolemia: A cohort study","volume":"248","author":"Raal","year":"2016","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jacl.2016.04.006_bib18","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.atherosclerosis.2013.01.007","article-title":"Spectrum of mutations and phenotypic expression in patients with autosomal dominant hypercholesterolemia identified in Italy","volume":"227","author":"Bertolini","year":"2013","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jacl.2016.04.006_bib19","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.atherosclerosis.2015.09.029","article-title":"Improved cardiovascular outcomes following temporal advances in lipid-lowering therapy in a genetically-characterised cohort of familial hypercholesterolemia homozygotes","volume":"243","author":"Thompson","year":"2015","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jacl.2016.04.006_bib20","doi-asserted-by":"crossref","first-page":"2202","DOI":"10.1161\/CIRCULATIONAHA.111.042523","article-title":"Reduction in mortality in subjects with homozygous familial Hypercholesterolemia associated with advances in lipid-lowering therapy","volume":"124","author":"Raal","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.jacl.2016.04.006_bib21","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1038\/gim.2015.14","article-title":"The importance of an integrated analysis of clinical, molecular, and functional data for the genetic diagnosis of familial hypercholesterolemia","volume":"17","author":"Benito-Vicente","year":"2015","journal-title":"Genet Med"},{"key":"10.1016\/j.jacl.2016.04.006_bib22","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/S0025-7125(16)31424-9","article-title":"The LDL receptor defect in familial hypercholesterolemia. Implications for pathogenesis and therapy","volume":"66","author":"Goldstein","year":"1982","journal-title":"Med Clin North Am"},{"key":"10.1016\/j.jacl.2016.04.006_bib23","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.atherosclerosis.2009.06.010","article-title":"Efficacy criteria and cholesterol targets for LDL-apheresis","volume":"208","author":"Thompson","year":"2010","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jacl.2016.04.006_bib24","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.transci.2009.05.013","article-title":"26 years of LDL-apheresis: a review of experience","volume":"41","author":"Borberg","year":"2009","journal-title":"Transfus Apher Sci"},{"key":"10.1016\/j.jacl.2016.04.006_bib25","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1016\/j.amjcard.2008.06.049","article-title":"Long-term safety and efficacy of low-density lipoprotein apheresis in childhood for homozygous familial hypercholesterolemia","volume":"102","author":"Hudgins","year":"2008","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacl.2016.04.006_bib26","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.jacl.2012.03.004","article-title":"Apheresis in homozygous familial hypercholesterolemia: the results of a follow-up of all Norwegian patients with homozygous familial hypercholesterolemia","volume":"6","author":"Graesdal","year":"2012","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.jacl.2016.04.006_bib27","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.atherosclerosis.2015.01.007","article-title":"Impact of LDL apheresis on aortic root atheroma in children with homozygous familial hypercholesterolemia","volume":"239","author":"Lefort","year":"2015","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jacl.2016.04.006_bib28","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.atherosclerosis.2016.02.009","article-title":"Homozygous familial hypercholesterolemia in childhood: Genotype-phenotype description, established therapies and perspectives","volume":"247","author":"Sanna","year":"2016","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jacl.2016.04.006_bib29","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1111\/imj.12444","article-title":"Liver transplantation for treatment of homozygous familial hypercholesterolaemia in an era of emerging lipid- lowering therapies","volume":"44","author":"Page","year":"2014","journal-title":"Intern Med J"},{"key":"10.1016\/j.jacl.2016.04.006_bib30","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/S0041-1345(02)03910-6","article-title":"Long-term outcome of liver transplantation for familial hypercholesterolemia","volume":"35","author":"Shrotri","year":"2003","journal-title":"Transplant Proc"}],"container-title":["Journal of Clinical Lipidology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1933287416301611?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1933287416301611?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,12]],"date-time":"2018-09-12T16:51:00Z","timestamp":1536771060000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1933287416301611"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7]]},"references-count":30,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016,7]]}},"alternative-id":["S1933287416301611"],"URL":"https:\/\/doi.org\/10.1016\/j.jacl.2016.04.006","relation":{},"ISSN":["1933-2874"],"issn-type":[{"value":"1933-2874","type":"print"}],"subject":[],"published":{"date-parts":[[2016,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical and molecular characteristics of homozygous familial hypercholesterolemia patients: Insights from SAFEHEART registry","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Lipidology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacl.2016.04.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 National Lipid Association. All rights reserved.","name":"copyright","label":"Copyright"}]}}